Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro

Provided By PR Newswire

Last update: Jan 30, 2024

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.